{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:22:58Z","timestamp":1787030578163,"version":"build-2736575974"},"reference-count":27,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.3892\/or.2013.2518","type":"journal-article","created":{"date-parts":[[2013,6,4]],"date-time":"2013-06-04T06:10:03Z","timestamp":1370326203000},"page":"1007-1013","source":"Crossref","is-referenced-by-count":12,"title":["Effect of bone marrow mesenchymal stem cells from blastic phase chronic myelogenous leukemia on the growth and apoptosis of leukemia cells"],"prefix":"10.3892","volume":"30","author":[{"given":"YUXIANG","family":"HAN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YING","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZHENG","family":"XU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JIE","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JINGCI","family":"YANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YAN","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YINTAO","family":"SHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JIANMIN","family":"LUO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2013,6,4]]},"reference":[{"key":"key20180107223711_b1-or-30-02-1007","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3892\/ol.2011.419","article-title":"Aberrant methylation in promoter-associated CpG islands of multiple genes in chronic myelogenous leukemia blast crisis","volume":"3","author":"Uehara","year":"2012","journal-title":"Oncol Lett"},{"key":"key20180107223711_b2-or-30-02-1007","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1182\/blood-2012-03-378919","article-title":"How I treat newly diagnosed chronic phase CML","volume":"120","author":"Cortes","year":"2012","journal-title":"Blood"},{"key":"key20180107223711_b3-or-30-02-1007","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0301-472X(00)00482-3","article-title":"Mesenchymal stem cells: biology and potential clinical uses","volume":"28","author":"Deans","year":"2000","journal-title":"Exp Hematol"},{"key":"key20180107223711_b4-or-30-02-1007","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature00870","article-title":"Pluripotency of mesenchymal stem cells derived from adult marrow","volume":"418","author":"Jiang","year":"2002","journal-title":"Nature"},{"key":"key20180107223711_b5-or-30-02-1007","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.biocel.2003.11.001","article-title":"Mesenchymal stem cells: clinical applications and biological characterization","volume":"36","author":"Barry","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"key":"key20180107223711_b6-or-30-02-1007","first-page":"941","article-title":"Immunosuppressive cells and tumour microenvironment: focus on mesenchymal stem cells and myeloid derived suppressor cells","volume":"26","author":"Bianchi","year":"2011","journal-title":"Histol Histopathol"},{"key":"key20180107223711_b7-or-30-02-1007","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1126\/science.276.5309.71","article-title":"Marrow stromal cells as stem cells for nonhematopoietic tissues","volume":"276","author":"Prockop","year":"1997","journal-title":"Science"},{"key":"key20180107223711_b8-or-30-02-1007","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1517\/14712598.8.3.255","article-title":"Role of mesenchymal stem cells in regenerative medicine: application to bone and cartilage repair","volume":"8","author":"Granero-Molto","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"key20180107223711_b9-or-30-02-1007","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/stem.269","article-title":"Mesenchymal stromal cells: current understanding and clinical status","volume":"28","author":"Salem","year":"2010","journal-title":"Stem Cells"},{"key":"key20180107223711_b10-or-30-02-1007","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1126\/science.1110364","article-title":"Bone marrow stromal cells generate muscle cells and repair muscle degeneration","volume":"309","author":"Dezawa","year":"2005","journal-title":"Science"},{"key":"key20180107223711_b11-or-30-02-1007","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3109\/10428199709055581","article-title":"VLA-4-mediated interactions between normal human hematopoietic progenitors and stromal cells","volume":"24","author":"Oostendorp","year":"1997","journal-title":"Leuk Lymphoma"},{"key":"key20180107223711_b12-or-30-02-1007","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1126\/science.1164390","article-title":"Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells","volume":"322","author":"Colmone","year":"2008","journal-title":"Science"},{"key":"key20180107223711_b13-or-30-02-1007","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1182\/blood.V96.10.3422","article-title":"SCF and G-CSF lead to the synergistic induction of proliferation and gene expression through complementary signaling pathways","volume":"96","author":"Duarte","year":"2000","journal-title":"Blood"},{"key":"key20180107223711_b14-or-30-02-1007","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/eji.200635840","article-title":"Colitogenic and non-colitogenic commensal bacteria differentially trigger DC maturation and Th cell polarization: an important role for IL-6","volume":"36","author":"Frick","year":"2006","journal-title":"Eur J Immunol"},{"key":"key20180107223711_b15-or-30-02-1007","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2141.1991.tb08614.x","article-title":"Long-term outcome of adults with acute myelogenous leukaemia: results of a prospective, randomized study of chemotherapy with a minimal follow-up of 7 years","volume":"77","author":"Bandini","year":"1991","journal-title":"Br J Haematol"},{"key":"key20180107223711_b16-or-30-02-1007","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/leu.2008.384","article-title":"Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1","volume":"23","author":"Zhu","year":"2009","journal-title":"Leukemia"},{"key":"key20180107223711_b17-or-30-02-1007","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/10428190701593636","article-title":"Chemotherapeutic treatment of bone marrow stromal cells strongly affects their protective effect on acute myeloid leukemia cell survival","volume":"49","author":"Moshaver","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"key20180107223711_b18-or-30-02-1007","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.4161\/cc.8.18.9545","article-title":"p38MAPK inhibitors attenuate cytokine production by bone marrow stromal cells and reduce stroma-mediated proliferation of acute lymphoblastic leukemia cells","volume":"8","author":"Gaundar","year":"2009","journal-title":"Cell Cycle"},{"key":"key20180107223711_b19-or-30-02-1007","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2174\/138945007780830827","article-title":"Targeting the leukemia microenvironment","volume":"8","author":"Konopleva","year":"2007","journal-title":"Curr Drug Targets"},{"key":"key20180107223711_b20-or-30-02-1007","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/sj.leu.2402924","article-title":"Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms","volume":"17","author":"Nefedova","year":"2003","journal-title":"Leukemia"},{"key":"key20180107223711_b21-or-30-02-1007","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/sj.leu.2402608","article-title":"Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins","volume":"16","author":"Konopleva","year":"2002","journal-title":"Leukemia"},{"key":"key20180107223711_b22-or-30-02-1007","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ccr.2010.10.032","article-title":"\u03b2-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells","volume":"18","author":"Yeung","year":"2010","journal-title":"Cancer Cell"},{"key":"key20180107223711_b23-or-30-02-1007","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1067\/msy.2001.115902","article-title":"Inhibition of p38 mitogen activated protein kinase increases lipopolysaccharide induced inhibition of apoptosis in neutrophils by activating extracellular signal-regulated kinase","volume":"130","author":"Sheth","year":"2001","journal-title":"Surgery"},{"key":"key20180107223711_b24-or-30-02-1007","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/sj.leu.2403653","article-title":"PI3-kinase\/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways","volume":"19","author":"Grandage","year":"2005","journal-title":"Leukemia"},{"key":"key20180107223711_b25-or-30-02-1007","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1038\/leu.2009.86","article-title":"Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia","volume":"23","author":"Valencia","year":"2009","journal-title":"Leukemia"},{"key":"key20180107223711_b26-or-30-02-1007","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1073\/pnas.0510423103","article-title":"Gene expression changes associated with progression and response in chronic myeloid leukemia","volume":"103","author":"Radich","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107223711_b27-or-30-02-1007","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/leu.2008.262","article-title":"Beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia","volume":"23","author":"Hu","year":"2009","journal-title":"Leukemia"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2013.2518\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T17:42:02Z","timestamp":1645638122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2013.2518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,4]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,6,4]]},"published-print":{"date-parts":[[2013,8]]}},"alternative-id":["10.3892\/or.2013.2518"],"URL":"https:\/\/doi.org\/10.3892\/or.2013.2518","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,4]]}}}